SC 13G

Company

Cellectar Biosciences, Inc.

Filed

October 25, 2022

Accession Number

0001104659-22-111018

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →